APA (7th ed.) Citation

NV, U., MM, B., JC, E., DA, D., K, M., J, M., . . . MF, B. (2025). Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer. Journal of surgical oncology, 131(7), 1293. https://doi.org/10.1002/jso.28070

Chicago Style (17th ed.) Citation

NV, Uboha, et al. "Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer." Journal of Surgical Oncology 131, no. 7 (2025): 1293. https://doi.org/10.1002/jso.28070.

MLA (9th ed.) Citation

NV, Uboha, et al. "Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer." Journal of Surgical Oncology, vol. 131, no. 7, 2025, p. 1293, https://doi.org/10.1002/jso.28070.